Ipilimumab/nivolumabVarious toxicities: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1891卷 / 1期

关键词：

D O I：

10.1007/s40278-022-09426-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：174 / 174

相关论文

共 50 条

[41] Infliximab/ipilimumab/nivolumabVarious toxicities: case report
Reactions Weekly, 2019, 1737 (1) : 162 - 162
[42] Avelumab/ipilimumab/nivolumabVarious toxicities: case report
Reactions Weekly, 2021, 1885 (1) : 93 - 93
[43] Cotrimoxazole/ipilimumab/nivolumabVarious toxicities: case report
Reactions Weekly, 2021, 1860 (1) : 130 - 130
[44] Ipilimumab/methylprednisolone/nivolumabVarious toxicities: case report
Reactions Weekly, 2021, 1886 (1) : 236 - 236
[45] Ipilimumab/nivolumabVarious endocrine toxicities : case report
Reactions Weekly, 2023, 1963 (1) : 304 - 304
[46] Cabozantinib/Ipilimumab/NivolumabVarious toxicities: case report
Reactions Weekly, 2024, 2029 (1) : 133 - 133
[47] Ipilimumab/lisinopril/nivolumabVarious toxicities: case report
Reactions Weekly, 2023, 1972 (1) : 191 - 191
[48] Ipilimumab/nivolumabVarious toxicities: 2 case report
Reactions Weekly, 2016, 1632 (1) : 172 - 172
[49] Infliximab/ipilimumab/nivolumabVarious toxicities: case report
Reactions Weekly, 2022, 1895 (1) : 219 - 219
[50] Empagliflozin/ipilimumab/nivolumabVarious toxicities: case report
Reactions Weekly, 2021, 1845 (1) : 173 - 173

← 1 2 3 4 5 →